In non-excitable cells, one major route for Ca 2؉ influx is through store-operated Ca 2؉ channels in the plasma membrane. These channels are activated by the emptying of intracellular Ca 2؉ stores, and in some cell types, particularly of hemopoietic origin, store-operated influx occurs through Ca 2؉ release-activated Ca 2؉ (CRAC) channels. However, little is known about the downstream consequences of CRAC channel activation. Here, we report that Ca 2؉ entry through CRAC channels stimulates arachidonic acid production, whereas Ca 2؉ release from the stores is ineffective even though the latter evokes a robust intracellular Ca 2؉ signal. We find that arachidonic acid released by Ca 2؉ entering through CRAC channels is used to synthesize the potent paracrine proinflammatory signal leukotriene C 4 (LTC 4 ). Both pharmacological inhibitors of CRAC channels and mitochondrial depolarization, which impairs CRAC channel activity, suppress arachidonic acid release and LTC 4 secretion. Thus, arachidonic acid release is preferentially stimulated by elevated subplasmalemmal Ca 2؉ levels due to open CRAC channels, suggesting that the enzyme is located close to the CRAC channels. Our results also identify a novel role for CRAC channels, namely the activation of a downstream signal transduction pathway resulting in the secretion of LTC 4 . Finally, mitochondria are key determinants of the generation of both intracellular (arachidonic acid) and paracrine (LTC 4 ) signals through their effects on CRAC channel activity.
In non-excitable cells, one major route for Ca 2؉ influx is through store-operated Ca 2؉ channels in the plasma membrane. These channels are activated by the emptying of intracellular Ca 2؉ stores, and in some cell types, particularly of hemopoietic origin, store-operated influx occurs through Ca 2؉ release-activated Ca 2؉ (CRAC) channels. However, little is known about the downstream consequences of CRAC channel activation. Here, we report that Ca 2؉ entry through CRAC channels stimulates arachidonic acid production, whereas Ca 2؉ release from the stores is ineffective even though the latter evokes a robust intracellular Ca 2؉ signal. We find that arachidonic acid released by Ca 2؉ entering through CRAC channels is used to synthesize the potent paracrine proinflammatory signal leukotriene C 4 (LTC 4 ). Both pharmacological inhibitors of CRAC channels and mitochondrial depolarization, which impairs CRAC channel activity, suppress arachidonic acid release and LTC 4 secretion. Thus, arachidonic acid release is preferentially stimulated by elevated subplasmalemmal Ca 2؉ levels due to open CRAC channels, suggesting that the enzyme is located close to the CRAC channels. Our results also identify a novel role for CRAC channels, namely the activation of a downstream signal transduction pathway resulting in the secretion of LTC 4 . Finally, mitochondria are key determinants of the generation of both intracellular (arachidonic acid) and paracrine (LTC 4 ) signals through their effects on CRAC channel activity.
In non-excitable cells, depletion of internal Ca 2ϩ stores opens store-operated Ca 2ϩ channels in the plasma membrane, a process called capacitative or store-operated Ca 2ϩ entry (1, 2) . In several cell types, particularly blood cells, store emptying activates a Ca 2ϩ -selective, inwardly rectifying, non-voltage-gated Ca 2ϩ current called I CRAC (2) . Despite considerable attention, neither the gating mechanism nor the molecular identity of these channels has been resolved. Two popular models for the activation of store-operated Ca 2ϩ entry are the diffusible messenger hypothesis, in which a mobile messenger plays a central role in channel activation, and conformational-coupling, which involves a direct physical interaction between inositol 1,4,5-trisphosphate receptors on the stores and the Ca 2ϩ channels in the plasma membrane (3, 4) . Molecular candidates for storeoperated Ca 2ϩ channels have been sought in the transient receptor potential (TRP) 1 superfamily, particularly among members of the canonical or TRPC subgroup. Although various TRPCs, as well as TRPV6, have been proposed to function as store-operated Ca 2ϩ channels, there is as yet no widely accepted candidate (5) .
The downstream consequences of CRAC channel activation are not clearly established. This reflects, at least in part, the fact that cells often express Ca 2ϩ influx pathways in addition to store-operated Ca 2ϩ entry (2, 6) , and the relative contributions of the different Ca 2ϩ entry pathways have not always been separated. However, in Jurkat T lymphocytes and rat basophilic leukemia (RBL) cells, electrophysiological studies have demonstrated that receptor engagement or exposure to the Ca 2ϩ ionophore ionomycin, the SERCA pump inhibitor thapsigargin, or dialysis with inositol 1,4,5-trisphosphate or high levels of Ca 2ϩ chelator, i.e. procedures that empty the internal stores, all activate I CRAC to similar extents, indicating that in these cell types I CRAC is the predominant electrogenic Ca 2ϩ entry pathway (7) (8) (9) (10) . In Jurkat T cells, Ca 2ϩ entry through CRAC channels is required for T cell receptor-mediated activation of nuclear transcription factors that regulate the expression of cytokine genes central to the immune response (11, 12) . In RBL-1 cells, a mast cell line, Ca 2ϩ entry via I CRAC contributes to regulated exocytosis (13) . Another important form of secretion from mast cells is the release of leukotrienes (LTs), a family of important lipid-derived signals that mediate inflammatory and allergic reactions (14) . LT production is initiated by the addition of molecular oxygen to arachidonic acid, a process catalyzed by the enzyme 5-lipoxygenase (15) . Cytosolic Ca 2ϩ is an important regulator of 5-lipoxygenase. It binds to the Nterminal C 2 -like domain of 5-lipoxygenase, and this is essential for translocation of the enzyme from the cytosol to the nucleus where it subsequently binds in close proximity to the integral membrane protein FLAP (5-lipoxygenase-activating protein) (15) (16) (17) (18) . Studies involving partially purified 5-lipoxygenase as well as cell homogenates have demonstrated that micromolar levels of Ca 2ϩ activate the enzyme (15, 18) . Formation of LTs is limited by the availability of arachidonic acid (19) . In many cell types, release of arachidonic acid from membrane phospholipids with an sn-2 arachidonyl chain by phospholipase A 2 is the major source for LT production (20 equally to LT formation or whether one type is preferentially involved.
Here, we have determined the involvement of Ca 2ϩ influx through CRAC channels in the regulation of arachidonic acid release and LTC 4 production in mast cells. We demonstrate that Ca 2ϩ entering through CRAC channels drives the release of arachidonic acid but that this is not mimicked by similar increases in cytosolic Ca 2ϩ following Ca 2ϩ release from the stores. Hence elevated subplasmalemmal Ca 2ϩ levels that arise following the opening of CRAC channels are preferentially linked to arachidonic acid generation. We find that arachidonic acid released by Ca 2ϩ influx through CRAC channels is metabolized by the 5-lipoxygenase pathway resulting in the secretion of LTC 4 . Importantly, mitochondrial depolarization, which impairs Ca 2ϩ influx through CRAC channels, prevents both the release of arachidonic acid and subsequent LTC 4 synthesis. We conclude that mitochondria, by regulating the extent of Ca 2ϩ entry through CRAC channels, are crucial determinants of Ca 2ϩ -dependent arachidonic acid production and therefore of subsequent downstream events such as the secretion of the key paracrine inflammatory signal LTC 4 .
EXPERIMENTAL PROCEDURES
Cell Culture-RBL-1 cells were bought from ATCC. Cells were cultured (37°C, 5% CO 2 ) in Dulbecco's modified Eagle's medium with 10% fetal bovine serum, 2 mM L-glutamine, and penicillin-streptomycin, as described previously (10, 23) . For patch clamp and Ca 2ϩ imaging experiments, cells were passaged onto glass coverslips and used 24 -48 h after plating.
I CRAC Recordings-Patch clamp experiments were conducted in the tight seal, whole-cell configuration at room temperature (20 -25°C) as described previously (10, 23) . Sylgard-coated, fire-polished pipettes had d.c. resistance of 4.2-5.5 megohms when filled with standard internal solution that contained (in mM): cesium glutamate 145, NaCl 8, MgCl 2 1, Mg-ATP 2, EGTA 0.1, HEPES 10, pH 7.2, with CsOH. A correction of ϩ10 mV was applied for the subsequent liquid junction potential that arose from this glutamate-based internal solution. Extracellular solution contained (in mM): NaCl 145, KCl 2.8, CaCl 2 10, MgCl 2 2, CsCl 10, D-glucose 10, and HEPES 10, pH 7.4, with NaOH. I CRAC was measured by applying voltage ramps (Ϫ100 to ϩ100 mV in 50 ms) at 0.5 Hz from a holding potential of 0 mV as described previously (10, 23) . Currents were filtered using an 8-pole Bessel filter at 2.5 kHz and digitized at 100 s. Currents were normalized by dividing the amplitudes (measured from the voltage ramps at Ϫ80 mV) by the cell capacitance. Capacitative currents were compensated before each ramp by using the automatic compensation of the EPC 9-2 amplifier. All leak currents were subtracted by averaging three ramp currents obtained just before application of thapsigargin and then subtracting this from all subsequent currents.
Ca 2ϩ Imaging-Ca 2ϩ imaging experiments were carried out at room temperature using the IMAGO CCD camera-based system from TILL Photonics as described previously (24) . Cells were alternately excited at 356 and 380 nm (20-ms exposures), and images were acquired every 2-3 s. Images were analyzed offline using IGOR Pro for Windows. Cells were loaded with Fura 2-AM (1 M) for 40 min at room temperature in the dark and then washed three times in standard external solution of composition (in mM) NaCl 145, KCl 2.8, CaCl 2 2, MgCl 2 2, D-glucose 10, and HEPES 10, pH 7.4, with NaOH. Cells were left for 15 min to allow further deesterification. [Ca 2ϩ ] was calculated using an in vivo type calibration obtained by patching the cells. The rate of Ca 2ϩ influx was obtained by measuring the initial slope of the Ca 2ϩ rise following readmission of Ca 2ϩ to cells with depleted stores (24) . Preparation of Cell Lysates-Attached cells from 6-cm plastic dishes were washed twice with PBS (composition in mM: NaCl 137, KCl 2.7, Na 2 HPO 4 8, KH 2 PO 4 1) and lysed with PBS buffer containing 0.5% Triton X-100. After thorough mixing by repeated pipetting, samples were incubated on ice for 10 min. Then the lysates were centrifuged at 8000 rpm for 5 min, and the supernatants were collected and stored at Ϫ70°C until used.
Western Blotting-Total cell lysates (10 g) were mixed with 5 l of glycerol, 0.1% bromphenol blue and analyzed by SDS-PAGE on a 10% gel. After electroblotting to nitrocellulose membrane, membranes were blocked with 5% nonfat dry milk in PBS buffer for 2 h at room temperature. Membranes were washed with PBS three times and then incubated with primary antibody for 1 h at room temperature. Anti-5-lipoxygenase antibody was from BD Transduction Laboratories and used at 1:3000 dilution. Then the membranes were washed with PBS again and incubated with 1:2000 dilution of peroxidase-linked antimouse IgG (Amersham Biosciences) for 1 h at room temperature. After washing with PBS, the bands were detected by an ECL-plus Western blotting detection system (Amersham Biosciences).
[ Reverse Transcriptase PCR Determination of 5-Lipoxygenase Expression in RBL Cells-Total RNA was extracted from RBL cells by a RNeasy Mini Kit (Qiagen). A reverse transcriptase reaction was performed on 3 g of extracted total RNA using the Superscript II Kit (Invitrogen) according to the manufacturer's instructions. Following cDNA synthesis, PCR was then performed with primers specific for 5-lipoxygenase (forward, 5Ј-AAAGAACTGGAAACACGTCAGAAA-3Ј, and reverse, 5Ј-AACTGGTGTGTACAGGGGTCAGTT-3Ј, with expected product size of 515 bp). 28 cycles of PCR were performed, with each cycle consisting of denaturation at 94°C for 30 s, annealing at 60°C for 1 min, and extension at 72°C for 1 min. The PCR products were electrophoresed through an agarose gel and visualized by ethidium bromide staining.
LTC 4 Measurements-Following stimulation of attached cells (grown in 6-cm plastic dishes) with thapsigargin, the supernatant was collected, and LTC 4 levels were measured by enzyme immunoassay (Cayman Chemicals, Ann Arbor, MI). Briefly, in 50 l of supernatant, leukotriene C 4 acetylcholinetransferase tracer and leukotriene C 4 antiserum were added to each enzyme immunoassay well. The plate was covered with plastic film and incubated for 18 h at room temperature. The wells were then emptied and rinsed five times with enzyme immunoassay washing buffer. 200 l of Ellman's reagent, prepared fresh, was added to each well, and the plate was placed on an orbital shaker for 1.5 h in the dark. Plate absorbance was measured at a wavelength of 405 nm.
RESULTS AND DISCUSSION

Thapsigargin-evoked Ca
2ϩ Influx but Not Ca 2ϩ Release Stimulates Arachidonic Acid Production-In RBL-1 cells, the SERCA pump inhibitor thapsigargin depletes internal Ca 2ϩ stores and subsequently activates I CRAC . Fig. 1A shows a typical whole-cell patch clamp experiment in which a cell was dialyzed with a pipette solution containing weak intracellular Ca 2ϩ buffer (0.1 mM EGTA). Following application of thapsigargin (2 M), a delay of several seconds elapsed before I CRAC started to activate. The current developed slowly, taking 201 Ϯ 54 s to reach steady state (6 cells). The current was identified as I CRAC from its I-V relationship (Fig. 1A, inset; very positive reversal potential, inward rectification and voltage-independent gating) and from the fact that removal of external Ca 2ϩ abolished the current (data not shown). We also measured the rate and extent of the cytosolic Ca 2ϩ increase to thapsigargin in cells preloaded with Fura 2 (Fig. 1B) ; the upper panel depicts RBL-1 cells loaded with Fura 2, and the lower panel shows typical Ca 2ϩ responses obtained after stimulation with thapsigargin. In the absence of external Ca 2ϩ , thapsigargin triggered Ca 2ϩ release from the internal stores, and the Ca 2ϩ signal decayed back to prestimulation levels over several minutes (Fig. 1B, lower panel) . In the presence of external Ca 2ϩ , however, the Ca 2ϩ signal was sustained. Aggregate data are summarized in Fig. 1C . Although the Ca 2ϩ signals in the absence and presence of external Ca 2ϩ were similar within 2 min of thapsigargin exposure, by 4 min a small but significant difference became apparent (Fig. 1C) in that the Ca 2ϩ signal was larger in the presence of external Ca 2ϩ . To probe the relationship between Ca 2ϩ influx through CRAC channels and arachidonic acid production, we measured arachidonic acid release at different times after stimulation with thapsigargin in the presence of external Ca 2ϩ . The results are shown in Fig. 1D . A small amount of release was seen at 2 min, and this increased substantially after 4 min of stimulation. No increase in arachidonic acid release could be detected following stimulation with thapsigargin for 4 min in Ca 2ϩ -free solution (Fig. 1E) , demonstrating that it is Ca 2ϩ influx and not Ca 2ϩ release from stores that stimulates arachidonic acid production. Ca 2ϩ -dependent release of arachidonic acid suggests a dominant role for cPLA 2 in our experiments; this PLA 2 isoform is activated by a rise in cytosolic Ca 2ϩ concentration (25, 26) and is expressed in RBL-1 cells (21). RBL-1 cells also express iPLA 2 , which can be activated by store depletion (22) . The finding that arachidonic acid release was suppressed by the removal of external Ca 2ϩ suggests that the contribution of iPLA 2 is minor under our conditions. To confirm this finding, we examined the effects of the relatively specific iPLA 2 inhibitor bromoenol lactone. However, as reported previously, bromoenol lactone substantially reduced store-operated Ca 2ϩ entry (22) , thereby potentially interfering with cPLA 2 activation. Hence agents such as bromoenol lactone could be problematic in distinguishing between the PLA 2 isoforms in intact cells. Finally, because cytosolic Ca 2ϩ was still elevated 4 min after thapsigargin application in Ca 2ϩ -free solution, and this was only a moderately smaller elevation than seen in the presence of external Ca 2ϩ (Fig. 1C) , it appears that the enzyme responsible for arachidonic acid release, likely cPLA 2 , is more responsive to subplasmalemmal microdomains of elevated Ca 2ϩ that accompany the opening of CRAC channels than to global increases in cytosolic Ca 2ϩ , at least over this range of Ca 2ϩ .
The CRAC Channel Inhibitors 2-Aminoethoxydiphenylborate (2-APB) and Gd
3ϩ Block Thapsigargin-dependent Stimulation of Arachidonic Acid Release-We designed experiments to identify the nature of the Ca 2ϩ entry pathway that drives arachidonic acid release. If Ca 2ϩ entry through CRAC channels stimulates arachidonic acid release, then one would expect inhibitors of CRAC channels to suppress this release. We tested this by using the store-operated channel blockers 2-APB and Gd 3ϩ . Although neither of these tools is specific, they do block store-operated entry and CRAC channels in a variety of cell types (27) . 20 M 2-APB blocks I CRAC in RBL-1 cells (28) and completely suppressed the Ca 2ϩ entry signal evoked by thapsigargin (Fig. 2, A and B) . 2-APB also prevented the ability of thapsigargin to release arachidonic acid (Fig. 2C) . Similar findings were obtained with 10 M Gd 3ϩ (Fig. 2C) . In addition to store-operated Ca 2ϩ entry, some cell types express arachidonate-regulated Ca 2ϩ -selective (ARC) channels, which are gated by arachidonic acid through a mechanism that does not involve store emptying (29, 30) . Two arguments suggest that under our experimental conditions, ARC channels make little contribution to the overall Ca 2ϩ signal. First, after a Ca 2ϩ plateau had been reached following readmission of external Ca 2ϩ to thapsigargin-treated cells, application of 20 M 2-APB inhibited the Ca 2ϩ signal by 81 Ϯ 11%. Although 2-APB inhibits CRAC channels, it has no effect on ARC channels (29) . Second, even modest Ca 2ϩ entry through the storeoperated pathway rapidly inhibits ARC channels through a mechanism involving calcineurin (30) . When store-operated entry is active, ARC channels are inhibited (30) .
Collectively, these results demonstrate that Ca 2ϩ entry through CRAC channels stimulates arachidonic acid release. 
Mitochondrial Depolarization Impairs Ca 2ϩ Entry through CRAC Channels and Prevents Arachidonic Acid Release-We
and others have previously established that energized mitochondria are required to support Ca 2ϩ entry through CRAC channels (11, 12, 23, 24) . Depolarization of mitochondria rapidly attenuates Ca 2ϩ influx. This arises, at least in part, from impaired mitochondrial Ca 2ϩ buffering such that Ca 2ϩ entry through CRAC channels can now feed back more effectively to curtail further Ca 2ϩ influx. We examined the effects of mitochondrial depolarization on Ca 2ϩ entry and subsequent arachidonic acid release. In these experiments, stores were depleted by exposing cells to thapsigargin in Ca 2ϩ -free solution for 8 min and then to antimycin A and oligomycin, rotenone and oligomycin, oligomycin alone, or Me 2 SO (solvent control) for a further 15 min in the continued presence of thapsigargin. Cell appearance did not seem to change much within this time frame (Fig. 3, A-C) . However, the rate of Ca 2ϩ entry, measured following readmission of external Ca 2ϩ , was significantly slower when mitochondria had been depolarized following exposure to antimycin A (inhibitor of complex III of the respiratory chain) and oligomycin (F 0 /F 1 ATP synthase inhibitor) (Fig. 3, D and E) . The rate of Ca 2ϩ influx was also reduced, albeit to a slightly lesser extent, when rotenone (10 M), an inhibitor of complex I of the respiratory chain, was used together with oligomycin instead of antimycin A (Fig. 3E) . However, oligomycin alone was without effect (Figs. 3, D and E) . These results are consistent with our previous reports (23, 24) and those of others (11, 12) , in which mitochondrial depolarization impaired CRAC channel activity.
Because mitochondrial depolarization impairs Ca 2ϩ entry through CRAC channels, we investigated the consequences of this on Ca 2ϩ -dependent arachidonic acid release. As shown in Fig. 3F , mitochondrial depolarization by the combination of either antimycin A and oligomycin or rotenone and oligomycin suppressed the release of arachidonic acid by thapsigargin. Oligomycin alone was again without effect. In Ca 2ϩ -free solution, thapsigargin failed to evoke any detectable arachidonic acid release (Fig. 1E) , and this remained the case in the presence of antimycin A and oligomycin. Taken together, these data suggest that functional mitochondria are required for Ca 2ϩ -dependent arachidonic acid production through their effects on maintaining CRAC channel activity.
Ca
2ϩ Entry through CRAC Channels Stimulates LTC 4 Production, a Downstream Consequence of Arachidonic Acid Release-We next investigated whether the release of arachidonic acid by Ca 2ϩ entering through CRAC channels was physiologically relevant. Biosynthesis of LTs, which are important components of the adaptive part of the immune response, depends on the availability of arachidonic acid. We therefore examined the relationship between Ca 2ϩ entry through CRAC channels and LT production, focusing on the cysteinyl LT LTC 4 . LTC 4 is a potent pro-inflammatory mediator that is secreted from cells and subsequently causes smooth muscle contraction, increased vascular permeability, and recruitment of other immune cells to the site of inflammation (14, 19) . As with other LTs, the initial step in the synthesis of LTC 4 is mediated by the 5-lipoxygenase enzyme. Reverse transcriptase PCR studies revealed that 5-lipoxgenase was present in RBL-1 cells (Fig. 4A) , and Western blotting confirmed protein expression (Fig. 4B) . Stimulation with thapsigargin resulted in a time-dependent increase in LTC 4 production (Fig. 4C) . A 2-min exposure to thapsigargin resulted in a small increase in LTC 4 synthesis; this increased substantially after 4 min but only slightly further after 8 min. This time course closely paralleled that for the Ca 2ϩ -dependent release of arachidonic acid (Fig. 1D ). Over this time period, thapsigargin did not alter the amount of 5-lipoxygenase present (Fig. 4B) , indicating that the increase in LTC 4 synthesis did not arise from an increase in the level of enzyme expression. Importantly, all LTC 4 production was suppressed when Ca 2ϩ influx through CRAC channels was prevented by removing external Ca 2ϩ (Fig. 4D ). Maneuvers that impair Ca 2ϩ entry through CRAC channels reduce the extent of arachidonic acid release (Fig. 2) . If arachidonic acid released through this route is used for LTC 4 synthesis, then interfering with CRAC channel activity should also interfere with LTC 4 production. We therefore examined the effects of the CRAC channel blockers 2-APB and Gd 3ϩ , both of which inhibit arachidonic acid release, on LTC 4 synthesis. As shown in Fig. 5A , these inhibitors suppressed LTC 4 production following a 4-min stimulation with thapsigargin in the presence of external Ca 2ϩ . We also examined the effects of mitochondrial depolarization on LTC 4 synthesis. Both antimycin A and rotenone (in combination with oligomycin) substantially reduced the production of LTC 4 following stimulation with thapsigargin (Fig. 5C ), whereas oligomycin pretreatment had no significant inhibitory effect. Collectively, these results indicate that Ca 2ϩ entering through CRAC channels stimulates arachidonic acid release, which is then used for the synthesis and subsequent secretion of LTC 4 .
Arachidonic acid has been reported to inhibit store-operated Ca 2ϩ entry in some systems (31, 32) . This raises the possibility of an intriguing negative feedback mechanism where Ca 2ϩ entry through CRAC channels releases arachidonic acid, which then suppresses further Ca 2ϩ influx. Although we found that arachidonic acid can partially inhibit both I CRAC and thapsigargin-evoked Ca 2ϩ influx in Fura 2-loaded cells by up to 70% (data not shown), this occurs only at relatively high concentra- tions (10 -50 M). As pointed out by Shuttleworth and colleagues (29) , these levels exceed the critical micelle concentration and could reflect nonspecific effects on the physical properties or structural integrity of the plasma membrane. At physiologically relevant concentrations (1-5 M; see Ref. 30) , arachidonic acid has no inhibitory effect on Ca 2ϩ entry in RBL-1 cells (data not shown). Importantly, 5-lipoxygenase is active in the presence of physiological levels of arachidonic acid (33) . Hence arachidonic acid can be metabolized to LTC 4 at concentrations that do not affect CRAC channel activity.
Conclusions-Our results offer new insight into the downstream consequences of CRAC channel activation. First, we demonstrate that Ca 2ϩ entry through CRAC channels results in the generation of the important signaling molecule, arachidonic acid. Arachidonic acid has numerous intracellular targets including stimulation of certain isoforms of protein kinase C and therefore can induce relatively long-lasting changes in cell function (34) . Even transient activation of CRAC channels following a 4-min exposure to thapsigargin was sufficient to generate a significant increase in arachidonate levels. Hence Ca 2ϩ -dependent release of arachidonic acid, ostensibly via stimulation of cPLA 2 , might be one way whereby a brief pulse of Ca 2ϩ influx through CRAC channels induces longer lasting downstream effects. Second, arachidonic acid release is activated by Ca 2ϩ influx but not Ca 2ϩ release from the stores, despite reasonably similar overall increases in cytosolic Ca 2ϩ concentration. Therefore cPLA 2 likely senses the spatial profile of the Ca 2ϩ signal and is preferentially activated by the elevated subplasmalemmal Ca 2ϩ concentration that arises upon the opening of CRAC channels. This is reminiscent of the tight coupling between store-operated Ca 2ϩ entry and activation of adenylate cyclase (35, 36) . Third, our results establish the importance of mitochondrial regulation of CRAC channel activity in determining subsequent downstream events. Mitochondrial depolarization, which impairs Ca 2ϩ entry through CRAC channels, suppressed both arachidonic acid release and the ensuing LTC 4 secretion. Mitochondrial gating of CRAC channels therefore has important physiological consequences in that it dictates whether a key intracellular (arachidonic acid) and then paracrine (LTC 4 ) signal is generated or not. Finally, in light of the fact that LTC 4 is a very potent pro-inflammatory mediator and has been linked to asthma (37), our results identify the CRAC channel as a rational therapeutic target for drugs aimed at treating such disorders.
